third rock ventures close congratulations to kala pharmaceuticals on its m initial public offering read more third rock launches tango therapeutics with m series a to develop novel medicines designed to target cancer vulnerabilities read more third rock announces sarah larson as partner read more third rock launches goldfinch bio with m series a to develop precision therapies for kidney disease read more partner abbie celniker named among boston business journals  innovation allstars read more congratulations to voyager therapeutics on being named one of the boston globes  top places to work read more third rock launches magenta therapeutics with m to apply new stem cell science to reboot the immune system read more allergan to acquire motus therapeutics read more third rock ventures raises  million oversubscribed fund read more partner profile charles homcy read more eleven biotherapeutics acquires viventia bio to create targeted protein therapeutics oncology company read more congratulations to our fierce  winners rhythm fulcrum and neon read more third rock launches relay therapeutics with m to build the world’s first dedicated drug discovery platform centered on protein motion read more take a look at what we’ve been up to for the past  years watch the video sign up for weekly portfolio company news alerts here  read more andrew stricos who has huntington’s disease and his wife tell their story at a luncheon hosted by third rock watch the video transforming healthcare  portfolio companies with more than  billion under management  clinical studies underway within our portfolio  diseases being targeted by our companies    of thousands patients impacted by portfolio company products and clinical trials ×   andrew stricos who has huntington’s disease and his wife tell their story at a luncheon hosted by third rock ×   partner charles homcy shares the story of founding myokardia close copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy contact third rock ventures contact submit interesting disruptive ideas here boston third rock ventures llc  newbury street rd floor boston ma  phone   fax   san francisco third rock ventures llc  mission bay blvd south suite  san francisco ca  phone   fax   copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy our people third rock ventures people we are a bicoastal multidisciplinary team that brings together the best of science strategy business and medicine partners alexis borisy partner abbie celniker phd partner neil exter partner kevin gillis partnerchief financial officer charles homcy md partner sarah larson partnerchief human resources officer mark levin partner craig muir partnerchief technology officer cary pfeffer md partner kevin starr partner robert tepper md partner venture partners frank t gentile phd venture partner mark a goldsmith md phd venture partner perry karsen venture partner christoph lengauer phd venture partner philip reilly md jd venture partner stephen sherwin md venture partner jeffrey tong phd venture partner barbara weber md venture partner entrepreneursinresidence jason coloma phd entrepreneurinresidence keith dionne entrepreneurinresidence jeffrey finer md phd entrepreneurinresidence brian jones phd entrepreneurinresidence robert kamen phd entrepreneurinresidence leon murphy phd entrepreneurinresidence glenn pierce md phd entrepreneurinresidence laurence turka md entrepreneurinresidence domain experts karina chmielewski senior director platform operations dina ciarimboli general counsel cynthia clayton head of communications john keilty general manager platform operations principals and associates brian albrecht phd principal tim funnell dphil principal melissa mccracken phd associate travis murdoch md principal vyas ramanan phd associate dominique verhelle phd mba principal finance  accounting alison connors cpa controller scott frechette cpa staff accountant ivan hyep senior finance manager greg mcgraw accounting manager jessica schoenig cpa staff accountant recruiting andrea dimella recruiting director tracy nicholson recruiting director chris robinson vice president recruiting administrative zoe angell executive assistant megan graziano manager of operations and administration linda heath executive assistant marcia hemphill office manager  west coast and executive assistant rhea kappa receptionistadministrative assistant laura vitale administrative assistant maribel laboy executive assistant ian miller administrative assistant corey o’keeffe event planner  communications angelo severino executive assistant tracy williams executive assistant at third rock people are our most valuable asset check our careers page to learn about career opportunities within the third rock portfolio third rock careers copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy media center third rock ventures media center   sign up for weekly portfolio company news alerts here download center third rock brochure third rock company profile third rock team profile news archives third rock news  events january    third rock ventures names sarah larson as partner» read more october    third rock ventures raises  million fund iv» read more september    third rock ventures’ venture partner phil reilly to receive the henri termeer lifetime achievement award at the th annual tribute to champions of hope» read more may    third rock ventures’ venture partner phil reilly to speak at massbio event to discuss his new book “orphan the quest to save children with rare disease”» read more april    third rock ventures partner robert tepper to moderate panel at the world medical innovation forum» read more april    third rock ventures partner cary pfeffer to present at xconomys exome whats hot in boston biotech » read more portfolio news agios pharmaceuticals july    agios to webcast conference call of second quarter  financial results on august   » press release  company news allena pharmaceuticals july    european commission grants orphan drug designation to allena pharmaceuticals investigational therapy for the treatment of primary hyperoxaluria » press release  company news blueprint medicines july    blueprint medicines to evaluate opportunities to advance rare disease discovery program in fibrodysplasia ossificans progressiva following discontinuation of collaboration with alexion » press release  company news cytomx therapeutics july    cytomx therapeutics to announce second quarter  financial results and provide midyear update » press release  company news blueprint medicines july    blueprint medicines to report second quarter  financial results on wednesday august   » press release  company news global blood therapeutics july    global blood therapeutics announces new employment inducement grants » press release  company news kala pharmaceuticals july    kala pharmaceuticals announces close of initial public offering and exercise of underwriters’ option » press release  company news neon therapeutics july    neon therapeutics and apexigen announce immunooncology clinical trial collaboration » press release  company news relay therapeutics july    relay therapeutics names deborah palestrant phd vice president of corporate development and strategy » press release  company news kala pharmaceuticals july    kala pharmaceuticals announces pricing of initial public offering » press release  company news news archives copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy insider trading  third rock ventures iii lp  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  third rock ventures iii lp select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm global blood therapeutics inc gbt third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert istarr kevin p owner    direct view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing other  pm nana voyager therapeutics inc vygr third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llcstarr kevin ptepper robert i owner   direct view other  pm nana editas medicine inc edit third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana editas medicine inc edit third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana editas medicine inc edit third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana editas medicine inc edit third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana editas medicine inc edit third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jstarr kevin ptepper robert i owner   direct view conversion  pm nana voyager therapeutics inc vygr third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llcstarr kevin ptepper robert i owner   direct view conversion  pm nana voyager therapeutics inc vygr third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llcstarr kevin ptepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana myokardia inc myok third rock ventures ii lpthird rock ventures gp ii lptrv gp ii llcthird rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana global blood therapeutics inc gbt third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view conversion  pm nana global blood therapeutics inc gbt third rock ventures iii lpthird rock ventures gp iii lptrv gp iii llclevin mark jtepper robert i owner   direct view   secformcom all rights reserved archives        fri  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  third rock ventures raises  million fund iii  business wire third rock ventures raises  million fund iii march    am eastern daylight time boston  san franciscobusiness wirethird rock ventures llc a venture capital firm focused on building healthcare companies today announced the final closing of fund iii raising  million in an oversubscribed fund with fund iii third rock will continue to execute on its strategy of launching building and supporting transformative healthcare companies since its inception third rock has raised more than  billion including fund iii for investments in healthcare companies with a particular emphasis on innovative product engines “we are grateful for the strong support for our model and significant interest from our existing and new investors” said kevin starr partner at third rock ventures “since  it has been our mission to be the preferred partner for entrepreneurs investors employees and industry to build great companies that discover and develop breakthrough products that make a difference for patients our funding to date has enabled us to successfully seed support or launch more than  important healthcare companies with fund iii we will continue on our mission launching up to  new companies focused on disruptive areas of science and medicine” collaborative approach to company building many of third rock’s portfolio companies have developed as part of collaborations with industry partners this collaborative company building approach enables third rock to address the unprecedented demand in the healthcare industry for innovative products “our approach has always been to seek out and explore unique collaborative models that are aligned with our mission and vision” said mark levin partner at third rock ventures “i am personally excited about the continued interest from our industry partners in working with third rock to identify new areas of exciting science and launch companies together through highvalue strategic partnerships” the third rock team since launching the firm third rock has grown its team to more than  people ranging from recognized industry leaders to recent graduates from many of the top science and medical institutions bringing a wide range of skills in science business strategy and medicine in conjunction with fund iii third rock anticipates expanding the team and is promoting mark a goldsmith md phd to partner in the firm “people are the single biggest asset at third rock” said robert tepper md partner at third rock ventures “third rocks unique company building approach relies on the collective experience of our growing family of collaborators advisors and company operators this depth and breadth across commercial business development rd drug discovery and product development allows us to partner with portfolio companies across multiple functions to translate scientific innovation into the reality of clinically meaningful medical products” about third rock ventures third rock ventures is a leading healthcare venture firm focused on investing and launching companies that make a difference in people’s lives the third rock team has a unique vision for ideating and building transformative healthcare companies working closely with our strategic partners and entrepreneurs third rock has an extensive track record for managing the value creation path to deliver exceptional performance for more information please visit the firm’s website at wwwthirdrockventurescom current third rock portfolio companies ablexis afferent pharmaceuticals agios pharmaceuticals alcresta allena pharmaceuticals alnara pharmaceuticals acquired by eli lilly  co in  bluebird bio blueprint medicines cibiem constellation pharmaceuticals cytomx therapeutics dc devices edimer pharmaceuticals eleven biotherapeutics ember therapeutics foundation medicine global blood therapeutics igenica jounce therapeutics kala pharmaceuticals lotus tissue repair acquired by shire plc in  myokardia ninepoint medical panoptica pharmaceuticals rhythm pharmaceuticals sage therapeutics seventh sense biosystems taris biomedical topica pharmaceuticals warp drive bio and zafgen contacts pure communications incdan budwick  release summary third rock ventures raises  million fund iii contacts pure communications incdan budwick  search advanced news search advanced news search log in sign up third rock ventures venture capital profile  venturedeal subscribecontact us homeoverviewfree trialsubscribeservicesuse casesapi feedsreportsfaq search download record   vcard  csv  pdf   venture investor name   third rock ventures investor type   venture capital status   active activity level          contact information contact   mark goldsmith title   partner   offices     address     newbury street rd floor  boston ma  usa  map phone     fax     address     mission bay blvd south  san francisco ca  usa  map phone     fax     website   wwwthirdrockventurescom     description  history industry focus   biopharmaceuticalcomponentsmedical devices  instruments company description   at third rock ventures our passion is the creation of meaningful life science companies that show high growth potential and are wellpositioned to make a difference in the marketplace we work collaboratively with entrepreneurs to focus on creating value from technologies that have the potential for delivering multiple product opportunities profile   social media   company news   facebook   youtube   transaction history   view transaction history     funds funding stage   seedearlyexpansion fund description   third rock ventures iv vintage date    fund amount    fund description   third rock ventures iii vintage date    fund amount    fund description   third rock ventures ii vintage date    fund amount    fund description   third rock ventures i vintage date    fund amount    total funds        investor names title name email social       partner borisy alexis partner celnicker abbie partner exter neil partner goldsmith mark partner homcy charles principal isacson christina principal kumar neil partner  advisor levin mark partner muir craig partner pfeffer cary partner  advisor starr kevin partner tartaglia lou partner tepper robert   free trial want unlimited access to the complete database with thousands of technology companies vcs and transactions for only  per month start your free  day trial now – no obligation or credit card required about venturedeal founded in  venturedeal is a database that provides the latest information about venture capital firms venturebacked technology companies and transactions throughout north america learn more » home overview service firms tech entrepreneurs venture investors services subscribe use cases faq terms of use privacy policy contact login  venturedeal inc menlo park ca all rights reserved third rock ventures iii lp top holdings whalewisdom search all search f filers only search sec filer search stocks only search mgmt inv cos only etfs only search active third rock ventures iii lp • boston ma • venture capital fund how do i update this listing third rock ventures iii is based out of boston whalewisdom has at least  dg filings in our database for third rock ventures iii the firm last filed a form d notice of exempt offering of securities on  the filing was for a pooled investment fund venture capital fund the notice included securities offered of pooled investment fund interests summary dg insider form  form d  create email alert × email notification log in or signup to see more advanced email alert options such as selecting any type of sec form multiple filers or classes of filers and much more or to simply have an email sent to you whenever we receive a new f filing from third rock ventures iii lp enter your email address below and choose submit your email cancel contact info third rock ventures iii lp  newbury street rd floor boston ma     business phone  sec sic codepharmaceutical preparations recent sec filings  filed on   filed on  sc ga filed on  sc g filed on   filed on   filed on   filed on   filed on   filed on  sc g filed on  current dg holdings stock sector shares held market value rank source source date voyager therapeutics inc vygr health care    g  editas medicine inc edit health care    g  schedule d and g events since  subscription required form   nonderivative insider transactions since  loading form d filings form d is a form to be used to file a notice of an exempt offering of securities with the securities and exchange commission form d contains basic information about the offering and the company form d filings filing date form type industry group securities offered total offering amount total amount sold total remaining  d pooled investment fund venture capital fund pooled investment fund interests    other issuers in filings name address no other issuers related parties included in filings name address relationship kevin starr subscription required executive officer mark levin subscription required executive officer na third rock ventures gp iii lp subscription required director na trv gp iii llc subscription required director robert tepper subscription required executive officer elevate your investments try it for free our investment strategy third rock ventures philosophy we build great companies in order to make a dramatic difference for patients our investment strategy discover launch build our mission  core values our investment strategy we discover launch and build great companies based on bold ideas that meet at the intersection of science strategy business and medicine  where transformational science meets operational reality  providing the best opportunity to make a dramatic difference in patients lives the third rock team our team has a proven record of translating disruptive technologies into valuable business enterprises we adhere to a “third rock forever” philosophy realizing that we have been phenomenally successful because of the contributions of the whole third rock team people are our greatest asset and we invest significant effort and resources to ensure we hire the best people at third rock and across the portfolio working closely with leading scientific and business visionaries as well as industry partners our team is focused on identifying opportunities to change the future of medicine and rigorously vets those ideas through our discovery process to develop the vision strategy and plan needed to succeed learn about our people  download third rock team fact sheet a formula for innovation we only invest in the best of those ideas we are actively involved in the early stages of our companies development typically serving as members of the founding management teams to build a strong foundation put in place the right people and culture and set the companies on a path to scientific and operational excellence view our portfolio  download third rock company fact sheet then we build on that foundation transitioning out of our interim leadership roles as we put in place rock star management teams we bring to bear the vast experience expertise and network of our team and across our portfolio to help our companies succeed management teams can tap into our network of experts across disciplines including science medicine business healthcare economics and regulatory strategy our partner development team leverages our relationships with decisionmakers in pharma to support business development efforts across our portfolio our strategy team serves as an advisory resource around critical business development financial and operational decisions our beyond great leadership program provides our portfolio leaders with a peertopeer network as well as tools and resources focused on shared elements of building transformational companies we build great companies together with our portfolio leaders scientific founders advisors and industry partners we try never to forget that medicine is for the people it is not for the profits the profits follow and if we have remembered that they have never failed to appear the better we have remembered it the larger they have been copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy portfolio third rock ventures portfolio our portfolio companies share a common goal – a fearless approach to addressing unmet medical needs through bold ideas and transformative science filter by all companies private public acquired cancer cardiovascular disease gastrointestinal infectious diseases metabolic disorders neurologicpsychiatric diseases ophthalmology hearing disorders rare genetic  orphan diseases renal respiratory urology devicetherapeutic technology diagnostic gene therapy personalized medicine technology platform biologics small molecules east coast companies west coast companies all companies copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy third rock ventures llc  financial services firm boston massachusetts  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthird rock ventures llc third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees share third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description third rock ventures llc is a ria based in boston ma information type ria head quarters boston ma  of employees none total assets na website location  newbury st boston ma   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets third rock ventures gp ii lp   third rock ventures gp iii lp   third rock ventures gp iv lp   third rock ventures gp lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership kevin paul starr effective officer december  less than  robert ira tepper effective officer december  less than  mark jay levin effective officer december  less than  kevin michael gillis chief finanacial officer april  less than  alexis borisy effective officer september  less than  abbie celniker effective officer september  less than  source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations brightscope  advisor pages  find a financial advisor or advisory firm getsearchtypedisplaynamesearchtype advisor funds firms k plans general search advisors advisory firms financial qa k plans funds search home    brightscope advisor pages    find a financial advisory firm advisor search firm search advisors by city find a financial advisory firm search firm name active firms only city state alabama alaska american samoa arizona arkansas california colorado connecticut delaware district of columbia florida georgia guam hawaii idaho illinois indiana iowa kansas kentucky louisiana maine maryland massachusetts michigan minnesota mississippi missouri montana nebraska nevada new hampshire new jersey new mexico new york north carolina north dakota northern marinara islands ohio oklahoma oregon pennsylvania puerto rico rhode island south carolina south dakota tennessee texas utah vermont virgin islands virginia washington west virginia wisconsin wyoming firm service areas financial planning estate planning comprehensive financial planning retirement planning college planning charitable planning other financial planning tax planning insurance life insurance health insurance longterm care insurance annuities property  casualty insurance business insurance other insurance pension consulting k b  defined benefit other pension consulting portfolio management individuals andor small businesses investment companies businesses or institutional clients other portfolio management accounting  tax tax advice other tax legal legal planning legal advice other legal other publication of periodicals or newsletters security ratings or pricing services market timing services selection of other advisors educational seminarsworkshops see all service areas find filters financialplanningfindfirm compensation arrangements no preference fixed fees  hourly charges  performancebased fees  none  fee only  assets under mgmt no preference   k  m  m  m  m  m  m  b  b  avg account balance no preference   k  k  k  k  m  m  m  m  m  financial advisory firm search results  results merrill lynch pierce fenner  smith incorporated ny ny  advisors  aum  b wells fargo advisors llc st louis mo  advisors  aum  b jp morgan securities llc manhattan ny  advisors  aum  b morgan stanley smith barney llc harrison ny  advisors  aum  b lpl financial llc boston ma  advisors  aum  b edward d jones  co lp des peres mo  advisors  aum  b ameriprise financial services inc minneapolis mn  advisors  aum  b ubs financial services inc weehawken nj  advisors  aum  b northwestern mutual investment servicesllc milwaukee wi  advisors charles schwab  co inc south beach ca  advisors mml investors services llc pine point ma  advisors  aum  b goldman sachs  co ny ny  advisors  aum  b strategic advisers inc boston ma  advisors  aum  b citigroup global markets inc new york ny  advisors  aum  b raymond james  associates inc st petersburg fl  advisors  aum  b      company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations third rock ventures iii lp  current holdings  fintelio third rock ventures iii lp current holdings from f d investorthird rock ventures iii lp current positions third rock ventures iii lp has disclosed  total holdings in their latest sec filings this investor has not filed a f which indicates it has under m in assets under management aum third rock ventures iii lp s top industries are chemicals and allied products sic   overview sec filings dg predictive value all third rock ventures iii lp holdings are listed in the following table this data is sourced from dg and f filings green rows indicate new positions red rows indicate closed positions add this fundto your dashboard this is a list of d and g filings made since the last quarterly f report if any file dateformsecurity prevshares currentshares changepercent prev valuex current valuex changepercent ‑‑ sc g edit  editas medicine inc   ‑‑ sc ga vygr  voyager therapeutics inc     fintel ir  find the right investors for your company instantly fintel ir combines the comprehensive fintel ownership database with machine learning to provide advanced tools to make investor outreach fast and easy learn more now become a power user join our private investing channel request membership third rock ventures iii lp  global blood therapeutics insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsthird rock ventures iii lpglobal blood therapeutics gbtten percent owner not rankedthird rock ventures iii lps performancethird rock ventures iii lp has not reported any informative transactions and therefore cannot be rankedhow are insiders ranked insider holdings  voyager therapeutics inc vygr  global blood therapeutics gbt  editas medicine inc editmsee the top stocks by insiders  insider rolesvoyager therapeutics inc vygr ten percent ownerglobal blood therapeutics gbt ten percent ownereditas medicine inc edit ten percent ownersee the top  corporate insiders  third rock ventures iii lps trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datevygrvoyager therapeutics incten percent owneruninformative sellapr  editeditas medicine incten percent owneruninformative sellaug  gbtglobal blood therapeuticsten percent ownersee all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top  corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by third rock ventures closes fund iii with m  pe hub subscribe to pe hub wire join over  of your peers get the mustread email for pevc professionals delivered to your inbox daily — for free us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions subscribe yes no registersign in a community for professionals in private capital third rock ventures closes fund iii with m march   by staff report follow buyouts print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub third rock ventures closes fund iii with m third rock ventures has raised  million for its third fund the firm which focuses on healthcare investing has operations in boston and san francisco continue reading on pe hub writes third rock ventures has raised  million for its third fund the firm which focuses on healthcare investing has operations in boston and san francisco press release third rock ventures llc a venture capital firm focused on building healthcare companies today announced the final closing of fund iii raising  million in an oversubscribed fund with fund iii third rock will continue to execute on its strategy of launching building and supporting transformative healthcare companies since its inception third rock has raised more than  billion including fund iii for investments in healthcare companies with a particular emphasis on innovative product engines “people are the single biggest asset at third rock” “we are grateful for the strong support for our model and significant interest from our existing and new investors” said kevin starr partner at third rock ventures “since  it has been our mission to be the preferred partner for entrepreneurs investors employees and industry to build great companies that discover and develop breakthrough products that make a difference for patients our funding to date has enabled us to successfully seed support or launch more than  important healthcare companies with fund iii we will continue on our mission launching up to  new companies focused on disruptive areas of science and medicine” collaborative approach to company building many of third rock’s portfolio companies have developed as part of collaborations with industry partners this collaborative company building approach enables third rock to address the unprecedented demand in the healthcare industry for innovative products “our approach has always been to seek out and explore unique collaborative models that are aligned with our mission and vision” said mark levin partner at third rock ventures “i am personally excited about the continued interest from our industry partners in working with third rock to identify new areas of exciting science and launch companies together through highvalue strategic partnerships” the third rock team since launching the firm third rock has grown its team to more than  people ranging from recognized industry leaders to recent graduates from many of the top science and medical institutions bringing a wide range of skills in science business strategy and medicine in conjunction with fund iii third rock anticipates expanding the team and is promoting mark a goldsmith md phd to partner in the firm “people are the single biggest asset at third rock” said robert tepper md partner at third rock ventures “third rock’s unique company building approach relies on the collective experience of our growing family of collaborators advisors and company operators this depth and breadth across commercial business development rd drug discovery and product development allows us to partner with portfolio companies across multiple functions to translate scientific innovation into the reality of clinically meaningful medical products” about third rock ventures third rock ventures is a leading healthcare venture firm focused on investing and launching companies that make a difference in people’s lives the third rock team has a unique vision for ideating and building transformative healthcare companies working closely with our strategic partners and entrepreneurs third rock has an extensive track record for managing the value creation path to deliver exceptional performance for more information please visit the firm’s website at wwwthirdrockventurescom current third rock portfolio companies ablexis afferent pharmaceuticals agios pharmaceuticals alcresta allena pharmaceuticals alnara pharmaceuticals acquired by eli lilly  co in  bluebird bio blueprint medicines cibiem constellation pharmaceuticals cytomx therapeutics dc devices edimer pharmaceuticals eleven biotherapeutics ember therapeutics foundation medicine global blood therapeutics igenica jounce therapeutics kala pharmaceuticals lotus tissue repair acquired by shire plc in  myokardia ninepoint medical panoptica pharmaceuticals rhythm pharmaceuticals sage therapeutics seventh sense biosystems taris biomedical topica pharmaceuticals warp drive bio and zafgen print email share via email separate multiple email addresses with commas share send me a copy email preview to from subject look at this story on pe hub third rock ventures closes fund iii with m third rock ventures has raised  million for its third fund the firm which focuses on healthcare investing has operations in boston and san francisco continue reading on pe hub writes dont miss out meet new and diverse managers in private equity venture capital and real estate at the third emerging manager connect east at new york citys harvard club click here for details sign up to our newsletter receive updates from our pe hub wire and top stories of the week newsletters first name last name email address us edition daily canada edition weekly we will not send you spam and we dont share your email address with rd parties i accept the terms and conditions you are now subscribed to the pehub wire and top stories of the week newsletters buyouts insiderargosy group llc produces several free newsletters that are sent directly to the email you provide at registration namely pe hub wire pe hub canada wire pe hub wire top story of the week buyouts daily and vcj alert to enable us to keep providing these services free of charge we reserve the right to contact you with special invitations to sample or purchase private equityrelated products by submitting this free subscription request for any of these products you are also consenting to this communication should you ever wish to unsubscribe from a particular communication you may activate the unsubscribe mechanism at the bottom of the email this will discontinue both the special invitations mentioned previously as well as your subscription to the weekly newsletter the information you provide will be safeguarded by argosy group llcbuyouts insider the company’s subsidiaries may use it to keep you informed of relevant products and services we occasionally allow reputable companies outside of the company to mail details of products which may be of interest to you as an international group we may transfer your data on a global basis for the purposes indicated above we will never share your email or contact details with any outside company however should you have any questions please do not hesitate to contact us email protected top posts kkr to buy nature’s bounty from carlyle by luisa beltran blackrock leads funding round for fintech platform icapital by iris dorbian platinum equity to buy united site services by luisa beltran the pe hub podcast episode two by staff report private equity jobs of the week priceline kpmg novaquest are hiring by eamon murphy the carveout curveball by pehublogger network raymond james expands team with new hire by iris dorbian blackstone acquires clarion events from providence by iris dorbian third rock ventures llc  financial services firm boston massachusetts  brightscope advisor pages getsearchtypedisplaynamesearchtype advisor funds firms k plans back to top homefirmpagesthird rock ventures llc third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees share third rock ventures llc overviewarticlesholdingsassetsservicesadvisorsleadershipfees overview description third rock ventures llc is a ria based in boston ma information type ria head quarters boston ma  of employees none total assets na website location  newbury st boston ma   articles insights there are no insights from this firm to display at this time procter  gamble plans competitive but exposure to company stock a risk to participants brightscope editorial firm links there are no links for this firm to display at this time holdings etf holdings there is no etf holding data from this firm to display at this time assets assets last updated on march   na total assets under management na total assets under advisement na accounts na estimated average account balance services firm services there is no services data available to display at this time firm client types there is no client type data to display at this time advisors current advisors  of advisors  there are no advisors from this firm to display at this time affiliated investment advisors and broker dealers name type total assets third rock ventures gp ii lp   third rock ventures gp iii lp   third rock ventures gp iv lp   third rock ventures gp lp   leadership ownership there is no ownership data available to display at this time executives and control persons name title tenure date  ownership kevin paul starr effective officer december  less than  robert ira tepper effective officer december  less than  mark jay levin effective officer december  less than  kevin michael gillis chief finanacial officer april  less than  alexis borisy effective officer september  less than  abbie celniker effective officer september  less than  source sec fees there is no compensation data available to display at this time company info about us newsroom careers contact blog explore k plan ratings advisor pages fund pages financial insights faq for advisors advisor pages spyglass for enterprise beacon social facebook twitter linkedin legal privacy policy terms of use copyright   brightscope inc all rights reserved your use of this service is subject to ourterms of useandprivacy policy information is provided as is and solely for informational purposes not for investment purposes or advicebrightscope is not a fiduciary under erisa brightscope is not endorsed by or affiliated with finra brightscope  cio  fww  global custodian  investor economics  liquidmetrix  market metrics  matrix solutions  planadviser  plan for life  plansponsor  simfund  strategic insight  the trade  strategic insight inc all rights reserved no reproduction without prior authorizations career opportunities third rock ventures careers overview opportunities beyond great element science « back to opportunities senior analog design engineer summary of role element science is building a world class medical device hardware design team we are looking for electrical engineers with a passion for creating devices that save lives the senior analog design engineer filling this role will own board level design involving microprocessors sensors and biosignal amplification and acquisition you will be part of a tightknit team on the cutting edge of wearable medical electronics if you have a proven track record of delivering robust safety critical electronic designs we would love to talk to you deliverables specify and design board level circuits for a class iii medical device schematic capture pcb layout design analysis component qualification analyze performance cost reliability and available tradeoffs of critical components write and dry run protocols for subsystem and system design verification qualifications msee with  years of experience or bsee with  years of experience multiple analog design product cycles experience with altium pads or other pcb design packages excellent written and verbal skills interested send a short introduction and your resume apply now senior ios engineer summary of role we are seeking a senior ios engineer to join our research and development team you will be developing the first version of our fda approved mobile application for a lifesaving medical wearable device this role will be our first mobile developer hire so you will have a high level of freedom and influence in how mobile development is done at element science going forward in addition to development you will be working closely with product design and quality to define the product features and setting best practices on process tools and collaboration between the teams deliverables launch the first version of the mobile application for clinical trials develop additional features for the commercial version of the mobile application set up development environment and plan with product when and who to hire to build both ios and android development teams work with product design and quality to define product features and agile development process that works within medical device development process ensure app readiness for clinical trials and contribute to documentation required by the fda qualifications  years experience developing software as an engineer proficient with ios technologies frameworks and tools such as swift objectivec ios sdk xcode core data cocoa touchpods  other ios libraries published an app to the apple store computer science degree or equivalent experience in medical devices wearables or bluetooth highly desired interested send a short introduction and your resume apply now senior backend engineer summary of role we are seeking a senior backend engineer to join our research and development team you will be building backend infrastructure from the ground up for lifesaving medical wearable devices that send continuous timeseries and diagnostic data not only for data scientists but also for analytics used by patients physicians and insurance companies as an early member of the team you will have a high level of freedom and influence in architecting the backend infrastructure and providing leadership in how it is deployed deliverables design and build a scalable and hipaa compliant backend infrastructure for data from medical wearable devices mobile applications and web tools create standard medical device software develop deliverables for regulatory submission build development qa staging and production environments that enable product development qa user testing and a lowrisk deployment to production develop deployment processes and monitoring to ensure high availability production environment qualifications  years experience developing software as an engineer  years experience provisioning physical or virtual production systems expert python development skills proficient with java javascript and c desired experience with svn and git experience with system components such as messaging services resource managers and load balancers comfortable working via configuration management tools eg chef puppet cfengine experience with automated testing integration delivery and containerization docker jails etc a plus computer engineering degree or equivalent interested send a short introduction and your resume apply now senior assembler summary of role element science is building a world class medical device hardware design team we are looking for assemblers with a passion for creating devices that save lives the assembler filling this role will be responsible for building our product you will be part of a tightknit team on the cutting edge of wearable medical electronics deliverables skills include manual hand assembly some soldering microscope work adhesive bonding electronic assembly operate tools and equipment such as heatmechanical press laser cutter soldering station digital multimeter tweezers wire crimperfirst list item qualifications  years of experience preferred  years medical device experience highly preferred fluent in english excellent written and verbal communication skills interested send a short introduction and your resume apply now firmware test engineer the company we develop technologies at the intersection of wearable devices precision medicine and lifesaving therapeutics our first product concept  funded by google ventures and third rock ventures  aims to redefine treatment for sudden cardiac death come join our growing team of engineers successful entrepreneurs and medical device professionals if you are interested making a real difference in patients lives and shaping the future of med tech in silicon valley summary of role this individual is responsible for designing and executing test plans for embedded software with the ultimate goal of automating the tests responsibilities include development and execution of verification test scripts this work will involve close collaboration with development and quality engineers • create and execute test strategies for key product features for release • find characterize and manage issues through resolution on hardware and firmware • automate manual test cases • write internal tools to help other developers and testers to use the product • work with developers and product managers to design test plans • create plans tests and tools for requirements verification and product validation • help integrate tools for managing requirements test suites and defects sample projects • work with product and development teams to understand the system design creative test cases that will validate the system as well as attempt to break it see features through from implementation to production produce solid verification reports • communicate results back to product owners and internal customers • convert manual test cases to python test cases on inhouse test automation framework • identify and implement process development and communication improvements necessary skills and experience • solid python programming experience • familiar with cc • testminded has a unique ability to break things • solid troubleshooting debugging and documentation skills • takes the initiative and is selfdriven additional desired experience • experience working with embedded hardware and software • experience with microcontroller protocols such as spi ic pwm jtag • experience with continuous integration systems • experience in writing and executing verification plans on medical devices aviation or other safety critical applications apply now electrical test engineer summary of role element science is looking for an experienced and passionate electrical test engineer to join our research and development group this individual will lead board level testing and provide feedback into design responsibilities include board bring up characterization and product verification if you have a proven track record of delivering robust systems we would love to talk to you deliverables apply system level methodologies to lead testing for a class iii medical device perform board level characterization testing of integrated hardware and firmware provide feedback into electrical design lead board level verification including tracing to requirements creating test protocols performing tests and documenting test reports qualifications electrical engineering background bs minimum ms preferred  years of experience preferred electrical development and testing of products with microprocessors and sensors excellent written and verbal communication skills with ability to work effectively across functions interested send a cover letter and your resume apply now electrical engineering technician summary of role we are seeking a handson experienced electrical engineering technician to join our research and development group this individual will work with engineering to enable electrical hardware development and testing deliverables assist in performing test procedures to evaluate all aspects of the development of new products rework prototype devices for bench and field testing perform verification testing on electrical designs operate standard electrical test equipment oscilloscope function generator power supply order materials and maintain an organized clean lab environment ensure lab equipment is in working order and is in calibration qualifications associate’s degree or equivalent from twoyear college or technical school or four years related experience andor training or equivalent combination of education or experience must be a selfstarter and be willing to work with others in a collaborative and flexible manner good soldering skills and solid understanding of electronics and electrical components computer skills including proficiency with microsoft word and excel interested send a short introduction and your resume apply now dsp engineer the company funded by google ventures and third rock ventures element science is developing a lifesaving medical device – an exciting product at the intersection of wearable devices and therapeutic medicine the company is a small and growing team of engineers serial entrepreneurs and medical device professionals seeking to redefine a product category with a clear concept enabling technology and a welldefined and important clinical target bring your expertise to work on a lifesaving wearable device in a nimble and exciting startup environment summary of role we are seeking a dsp engineer to join our research and development group this individual will be responsible for developing embedded lowpower signal processing algorithms to extract high quality cardiac data from wearable sensor data this work will involve using and inventing timeseries signal processing and implementing machine learning techniques to outperform stateoftheart algorithms and trained experts the opportunity involves developing robust techniques for biological signal processing that work in realtime across a variety of body types and environmental conditions with a battery operated device deliverables  develop timefrequency approaches to measure high quality cardiac electrical data  work with hardware team to design analog frontend and digital frontend tradeoffs  write and validate embedded code for onchip digital signal processing qualifications  ee or cs background required ms  years or bs  years of experience  expert in embedded system signal processing eg c c  proficiency in signal processing fundamentals with particular focus on timefrequency techniques eg fourier and wavelet filtering and descriptive statistics  appreciation for quality system risk management and medical product development processes  outstanding written and verbal communication  bonus knowledge and interest in machine learning techniques interested candidates should send a cover letter and resume apply now director of service operations summary of role the director of service operations will work to define the service operations strategy and lifecycle management of the element science product and then implement the strategy by building capabilities the element science product will have a complex service component that will be mission critical to the success of the company it is anticipated that service operations would include a customer service call center shipping and logistics operations sales operations and reimbursement and billing support the ideal candidate will be both strategic and operational who understands logistics customer service and general operations the ideal candidate should have practical service operations experience preferably in medical devices and an entrepreneurial approach to problem solving deliverables develop service operations strategy consistent with providing an outstanding customer experience develop a logistics and operational system that ensures patients always have a supply of product while strictly following a medical device quality system create tactical plan to build service operations capabilities to support us pivotal trial and commercial launch hire and lead service operations staff customer service call center shipping  logistics reimbursement and billing support etc define relevant sops and training to build an efficient and highquality service organization build and lead a system that coordinates customers patients complaint promotional and business to ensure efficient effective customer service and information flow own the interface between service operations and manufacturing to support element science devices for final vv and capable of supporting the simulated use study and pivotal trial provide input to marketing and user experience design to create an outstanding customer experience through service estimate refine and manage the performance quality and cost of the service operations organization collaborate with quality to establish appropriate service to support element science systems for pivotal trial collaborate with marketing to architect distribution and reverse logistics pathways qualifications bs in engineering  science  operations  supply chain management or other relevant degree required masters in a related field or mba are preferred  years of medical device experience  years of management experience proven track record in driving the development and delivery of efficient and effective service operations excellent written and verbal communication skills interested send a short introduction and your resume apply now clinical affairs manager summary of role we are seeking a clinical affairs manager to join our growing medical technology company this individual will be responsible for managing clinical protocols to enable clinical evaluations of our technology managing study timelines of multicenter trials performing clinical site evaluation to assess site suitability clinical site onboarding and initiation to use our technology clinical site staff training on study design requirements and device use ensuring site compliance with protocol including patient identification and followup managing clinical site data collection and site monitoring collaborating to interpret and describe data generated from the clinical work communicating clinical results to rd team deliverables all aspects of clinical protocols cip crf icf identificationactivation of appropriate clinical sites negotiation of site agreements execution of clinical study management according to gcp guidelines management of data collection and monitoring per study plan preparation of clinical study reports qualifications science or engineering background required ms or bs with  years of experience evidence of data analysis and presentation of clinical data to engineers and scientists appreciation for quality system risk management and medical product development processes interested send a short introduction and your resume apply now application verification engineer the company we develop technologies at the intersection of wearable devices precision medicine and lifesaving therapeutics our first product concept  funded by google ventures and third rock ventures  aims to redefine treatment for sudden cardiac death come join our growing team of engineers successful entrepreneurs and medical device professionals if you are interested making a real difference in patients lives and shaping the future of med tech in silicon valley summary of role we are seeking an application verification engineer to join our research and development group this individual will be responsible for testing the software application for a class  medical device this work will involve close collaboration with application and quality engineers to write verification protocols and run verification testing deliverables  develop verification protocol for mobile device and backend software  develop test environment for running verification testing  run verification testing to product verification report  coordinate work with inhouse and external consultants qualifications  sw ee or cs background required bs with  or ms with  years of experience  outstanding communication skills with engineers marketing and clinical team members  outstanding written skills to define and document software architecture  experience in writing and executing verification plans on medical devices  experience writing verification reports on medical devices  experience testing graphical user interfaces  experience with mobile applications  programming experience in a computer language  flexible and versatile style to support individual productivity and interactions with outside consultants  desirable to have experience in python programming automated testing and ble communication contact interested candidates should send a cover letter and resume apply now copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy career opportunities third rock ventures careers overview opportunities beyond great opportunities industries all jobs cancer cardiovascular disease gastrointestinal infectious diseases metabolic disorders neurologicpsychiatric diseases ophthalmology rare genetic  orphan diseases renal respiratory urology devicetherapeutic technology diagnostic gene therapy personalized medicine technology platform biologics small molecules functions all functions business development clinical research data science engineering hardware engineering qa engineering software it and informatics manufacturing operations project and program management rd regulatory affairs research sciassocmgr sales technicalcustomer support process engineer drug product  newton ma us senior systems engineer and security specialist  cambridge ma us animal technician invivo immunooncology  cambridge ma us senior scientist – computational chemistry  cambridge ma us senior desktop and lab support engineer  cambridge ma us scientist  senior scientist pharmacology  cambridge ma us biomarker researcher  cambridge ma us clinical scientist  cambridge ma us clinical trial manager  cambridge ma us medical director  cambridge ma us development project management  cambridge ma us senior scientist  cambridge ma us vice president of biology  cambridge ma us research associatesenior research associate vitro pharmacology  boston ma us associate director pharmacology  cambridge ma us associate directordirector  business development  cambridge ma us electrical test engineer  san francisco ca us firmware test engineer  san francisco ca us electrical engineering technician  san francisco ca us clinical affairs manager  san francisco ca us senior assembler  san francisco ca us application verification engineer  san francisco ca us dsp engineer  san francisco ca us director of service operations  san francisco ca us senior backend engineer  san francisco ca us senior analog design engineer  san francisco ca us senior ios engineer  san francisco ca us lead clinical trial manager  cambridge ma us lead cmc analytical development  cambridge ma us senior manager regulatory affairs  cambridge ma us manager clinical informatics  cambridge ma us research associate in vivo pharmacology  cambridge ma us scientistsr scientist in vivo pharmacology  cambridge ma us scientist vaccine immunologist  cambridge ma us senior scientist analytical chemistry  cambridge ma us scientist t cell immunology  cambridge ma us research associate  associate scientist biochemistry protein expression and purification  cambridge ma us bioinformatics engineer  cambridge ma us senior scientist peptide chemistry  cambridge ma us head of immunology  cambridge ma us associate scientistscientist i analytical chemistry  cambridge ma us clinical data manager  cambridge ma us senior clinical research associate  bedford ma us territory manager sales  united states of america senior scientist dna encoded chemistry library discovery  san francisco ca us research associate  senior research associate discovery biology  san francisco ca us scientist i medicinal chemistry  san francisco ca us research associate – cell biology phenotypic and high throughput screening  redwood city ca us associate directordirector dmpk  redwood city ca us scientistssr scientists biology  redwood city ca us scientistsenior scientist medicinal chemistry  redwood city ca us sr research associate medicinal chemistry  redwood city ca us senior research associate cell biology phenotypic and high throughput screening  redwood city ca us scientist ii medicinal chemistry  redwood city ca us director cmc  redwood city ca us senior scientist iiassociate director safety pharmacology and toxicology  redwood city ca us senior scientist medicinal chemistry  redwood city ca us senior project manager  associate director project management  redwood city ca us copyright   third rock ventures llc all rights reserved terms of use privacy policy terms of use privacy policy